Status:
UNKNOWN
Optimising Cardiovascular Health in Endometrial Cancer Survivors
Lead Sponsor:
University of Manchester
Conditions:
Endometrial Cancer
Cardiovascular Diseases
Eligibility:
FEMALE
18-110 years
Brief Summary
Women successfully treated for endometrial cancer remain at higher risk of dying than women without a history of the disease, predominately due to an excess risk of cardiovascular disease. Our previou...
Detailed Description
A comprehensive cardiovascular risk assessment will be performed as part of clinical care on women previously treated for endometrial cancer at the study site. This will include a focused interview, e...
Eligibility Criteria
Inclusion
- Previous treatment for endometrial cancer within the last four years
- Able to consent to participation in the study
Exclusion
- Currently undergoing treatment for endometrial cancer recurrence
- Anticipated life expectancy \<12 months
- To cease routine surveillance in next 12 months
- Not registered with a General Practitioner (GP)
Key Trial Info
Start Date :
February 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05216913
Start Date
February 9 2022
End Date
October 1 2024
Last Update
May 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Mary's Hospital
Manchester, United Kingdom, M13 9WL